Kimiaki Utsugisawa Selected Research

Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)

9/2013	Overlooked non-motor symptoms in myasthenia gravis.
2/2010	Factors associated with response to calcineurin inhibitors in myasthenia gravis.
11/2009	Autoimmune targets of heart and skeletal muscles in myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimiaki Utsugisawa Research Topics

Disease

43	Myasthenia Gravis 06/2024 - 01/2002
9	Thymoma (Thymic Carcinoma) 01/2021 - 08/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 07/2011
4	Thymus Hyperplasia 01/2018 - 01/2003
3	Muscle Weakness 01/2024 - 01/2017
3	Myocarditis (Carditis) 09/2013 - 08/2007
3	Hypoxia (Hypoxemia) 04/2005 - 05/2002
2	Disease Progression 01/2023 - 01/2023
2	Headache (Headaches) 01/2023 - 12/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2009 - 08/2007
2	Guillain-Barre Syndrome 09/2006 - 01/2003
1	Fatigue 02/2024
1	COVID-19 01/2023
1	Fever (Fevers) 01/2023
1	Infections 01/2023
1	Meningococcal Infections 01/2019
1	Meningococcal Meningitis 12/2017
1	Thymus Neoplasms (Thymus Neoplasm) 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Osteoporosis 01/2015
1	Osteoporotic Fractures 01/2015
1	Heart Diseases (Heart Disease) 09/2013
1	Alopecia Areata 09/2013
1	Taste Disorders (Taste Disorder) 09/2013
1	Isaacs Syndrome (Neuromyotonia) 09/2013
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2013
1	Pure Red-Cell Aplasia 09/2013
1	Hypertension (High Blood Pressure) 01/2012
1	Blepharoptosis (Ptosis, Eyelid) 07/2011
1	Rhabdomyosarcoma 08/2007
1	Hyperplasia 07/2007
1	Hypesthesia (Numbness) 09/2006
1	Herpes Zoster 09/2006
1	Chronic Hepatitis C 06/2005
1	Muscular Diseases (Myopathy) 06/2005
1	Hypothyroidism 06/2005

Drug/Important Bio-Agent (IBA)

17	Cholinergic ReceptorsIBA 06/2024 - 01/2003
12	AutoantibodiesIBA 01/2024 - 08/2007
7	glucose-mannose-glucoseIBA 04/2024 - 01/2019
7	AntibodiesIBA 01/2018 - 01/2003
6	eculizumab FDA Link 04/2024 - 12/2017
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2005
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 01/2011
4	zilucoplanIBA 02/2024 - 05/2021
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 09/2006
3	Complement System Proteins (Complement)IBA 04/2024 - 12/2017
3	Methylprednisolone FDA LinkGeneric 01/2023 - 01/2002
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2013 - 11/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 01/2010
3	Calcineurin InhibitorsIBA 01/2012 - 02/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 02/2010 - 02/2003
2	muskIBA 06/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2021
2	Phosphotransferases (Kinase)IBA 12/2023 - 01/2023
2	SteroidsIBA 01/2020 - 01/2010
2	Complement Inactivating AgentsIBA 12/2019 - 12/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 09/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2011 - 11/2009
2	ConnectinIBA 01/2011 - 11/2009
2	phytobacteriomycin (PBM)IBA 02/2003 - 01/2003
2	PhytohemagglutininsIBA 02/2003 - 01/2003
2	Interleukin-2 (IL2)IBA 02/2003 - 01/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2024
1	ravulizumabIBA 04/2024
1	rozanolixizumabIBA 01/2023
1	neonatal Fc receptorIBA 01/2023
1	Complement C5 (Complement 5)IBA 05/2021
1	Immunoglobulin Fc FragmentsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	margatoxinIBA 09/2019
1	Rituximab (Mabthera)FDA Link 12/2017
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 11/2016
1	GlucocorticoidsIBA 01/2015
1	AutoantigensIBA 09/2013
1	Immunologic Factors (Immunomodulators)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 09/2012
1	CreatinineIBA 01/2012
1	glucose-regulated proteinsIBA 08/2011
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2011
1	Naphazoline (All Clear)FDA LinkGeneric 07/2011
1	EpitopesIBA 01/2011
1	Muscle Proteins (Muscle Protein)IBA 01/2011
1	2-methylphenyl cinnamateIBA 01/2010
1	SulfurIBA 08/2007
1	Protein Kinase CIBA 07/2007
1	Protein Kinase C-thetaIBA 07/2007
1	AntigensIBA 07/2007
1	Thyroid HormonesIBA 06/2005
1	Interferon-alpha (Interferon Alfa)IBA 06/2005
1	thyrotropin-binding inhibitory immunoglobulinIBA 06/2005
1	Angiotensin IIIBA 04/2005

Therapy/Procedure

10	Therapeutics 01/2023 - 01/2002
9	Activities of Daily Living (ADL) 01/2024 - 12/2017
6	Thymectomy 09/2019 - 01/2003
2	Immunotherapy 01/2023 - 01/2023
2	Plasmapheresis 01/2021 - 01/2011
1	Biological Therapy 01/2023
1	Plasma Exchange 12/2017
1	Adjuvant Radiotherapy 05/2013
1	Immunomodulation 11/2009